Join to View Full Profile
9200 W Wisconsin Ave# NeoplastMilwaukee, WI 53226
Phone+1 414-805-4600
Fax+1 414-805-6808
Dr. Bylow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2004 - 2007
Vanderbilt University Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Wisconsin School of Medicine & Public HealthClass of 2000
Certifications & Licensure
WI State Medical License 2007 - 2027
IL State Medical License 2003 - 2008
American Board of Internal Medicine Geriatric Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
- Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Publications & Presentations
PubMed
- Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors.Iwalola Awoyinka, Patricia Sheean, Paula Papanek, Kathryn E Flynn, Kathryn Bylow
Contemporary Clinical Trials. 2026-02-01 - 1 citationsSuccessful Targeting of SomaticAlterations With Belzutifan in Two Cases.Bicky Thapa, Aditya Shreenivas, Kathryn Bylow, Hui-Zi Chen, Ben George
Journal of Immunotherapy and Precision Oncology. 2024-11-01 - 1 citationsAn Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer.Sailaja Kamaraju, June McKoy, Grant R Williams, Nikesha Gilmore, Christina Minami
Current Oncology Reports. 2024-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
